Global Bispecific Antibody Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Bispecific Antibody Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2046761
  • Published Date :
    June 1, 2022
  • Number of Pages :
    300.0

Product Description

The Bispecific Antibody market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Bispecific Antibody market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Bispecific Antibody Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Bispecific Antibody market are:
AstraZeneca (MedImmune)
Affimed Therapeutics
Regeneron Pharmaceuticals
Jounce Therapeutics
Eli Lilly
MacroGenics
Sanofi
Genentech
Pieris
Neovii Biotech
Ablynx
Emergent BioSolutions
Merus
Genmab
OncoMed Pharmaceuticals
Chugai Pharmaceutical
EMD Serono
Immunomedics
Roche
Adimab
Amgen
NovImmune SA

Most important types of Bispecific Antibody products covered in this report are:
Mab or Peptide
BiTE
Bispecific mAb
CAR-T
ADC
Small Molecule

Most widely used downstream fields of Bispecific Antibody market covered in this report are:
Primarily Oncology
Solid Tumors
Inflammation
Cardiovascular
General Medicine

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Bispecific Antibody Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Bispecific Antibody
1.3 Bispecific Antibody Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Bispecific Antibody Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Bispecific Antibody
1.4.2 Applications of Bispecific Antibody
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Bispecific Antibody Industry Trends
1.5.2 Bispecific Antibody Drivers
1.5.3 Bispecific Antibody Market Challenges
1.5.4 Bispecific Antibody Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Bispecific Antibody Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Bispecific Antibody Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Bispecific Antibody Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Bispecific Antibody
2.2.1 Major Players Manufacturing Base of Bispecific Antibody in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Bispecific Antibody Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Bispecific Antibody
2.3.3 Labor Cost of Bispecific Antibody
2.4 Market Channel Analysis of Bispecific Antibody
2.5 Major Down Stream Customers by Application

3 Global Bispecific Antibody Market, by Type
3.1 Global Bispecific Antibody Revenue and Market Share by Type (2018-2021)
3.2 Global Bispecific Antibody Production and Market Share by Type (2018-2021)
3.3 Global Bispecific Antibody Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Bispecific Antibody Revenue and Growth Rate of Mab or Peptide
3.3.2 Global Bispecific Antibody Revenue and Growth Rate of BiTE
3.3.3 Global Bispecific Antibody Revenue and Growth Rate of Bispecific mAb
3.3.4 Global Bispecific Antibody Revenue and Growth Rate of CAR-T
3.3.5 Global Bispecific Antibody Revenue and Growth Rate of ADC
3.3.6 Global Bispecific Antibody Revenue and Growth Rate of Small Molecule
3.4 Global Bispecific Antibody Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Bispecific Antibody Market, by Application
4.1 Downstream Market Overview
4.2 Global Bispecific Antibody Consumption and Market Share by Application (2018-2021)
4.3 Global Bispecific Antibody Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Bispecific Antibody Consumption and Growth Rate of Primarily Oncology (2018-2021)
4.3.2 Global Bispecific Antibody Consumption and Growth Rate of Solid Tumors (2018-2021)
4.3.3 Global Bispecific Antibody Consumption and Growth Rate of Inflammation (2018-2021)
4.3.4 Global Bispecific Antibody Consumption and Growth Rate of Cardiovascular (2018-2021)
4.3.5 Global Bispecific Antibody Consumption and Growth Rate of General Medicine (2018-2021)

5 Global Bispecific Antibody Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Bispecific Antibody Revenue and Market Share by Region (2018-2021)
5.2 Global Bispecific Antibody Consumption and Market Share by Region (2018-2021)
5.3 Global Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Bispecific Antibody Market Under COVID-19
5.4.2 North America Bispecific Antibody SWOT Analysis
5.5 Europe Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Bispecific Antibody Market Under COVID-19
5.5.2 Europe Bispecific Antibody SWOT Analysis
5.6 China Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Bispecific Antibody Market Under COVID-19
5.6.2 China Bispecific Antibody SWOT Analysis
5.7 Japan Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Bispecific Antibody Market Under COVID-19
5.7.2 Japan Bispecific Antibody SWOT Analysis
5.8 Middle East and Africa Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Bispecific Antibody Market Under COVID-19
5.8.2 Middle East and Africa Bispecific Antibody SWOT Analysis
5.9 India Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Bispecific Antibody Market Under COVID-19
5.9.2 India Bispecific Antibody SWOT Analysis
5.10 South America Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Bispecific Antibody Market Under COVID-19
5.10.2 South America Bispecific Antibody SWOT Analysis
5.11 South Korea Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Bispecific Antibody Market Under COVID-19
5.11.2 South Korea Bispecific Antibody SWOT Analysis
5.12 Southeast Asia Bispecific Antibody Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Bispecific Antibody Market Under COVID-19
5.12.2 Southeast Asia Bispecific Antibody SWOT Analysis

6 Global Bispecific Antibody Production by Top Regions (2018-2021)
6.1 Global Bispecific Antibody Production by Top Regions (2018-2021)
6.2 North America Bispecific Antibody Production and Growth Rate
6.3 Europe Bispecific Antibody Production and Growth Rate
6.4 China Bispecific Antibody Production and Growth Rate
6.5 Japan Bispecific Antibody Production and Growth Rate
6.6 India Bispecific Antibody Production and Growth Rate

7 Global Bispecific Antibody Consumption by Regions (2018-2021)
7.1 Global Bispecific Antibody Consumption by Regions (2018-2021)
7.2 North America Bispecific Antibody Consumption and Growth Rate
7.3 Europe Bispecific Antibody Consumption and Growth Rate
7.4 China Bispecific Antibody Consumption and Growth Rate
7.5 Japan Bispecific Antibody Consumption and Growth Rate
7.6 Middle East & Africa Bispecific Antibody Consumption and Growth Rate
7.7 India Bispecific Antibody Consumption and Growth Rate
7.8 South America Bispecific Antibody Consumption and Growth Rate
7.9 South Korea Bispecific Antibody Consumption and Growth Rate
7.10 Southeast Asia Bispecific Antibody Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 AstraZeneca (MedImmune) Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Bispecific Antibody Product Profiles, Application and Specification
8.2.3 AstraZeneca (MedImmune) Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Affimed Therapeutics Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Bispecific Antibody Product Profiles, Application and Specification
8.3.3 Affimed Therapeutics Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Regeneron Pharmaceuticals Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Bispecific Antibody Product Profiles, Application and Specification
8.4.3 Regeneron Pharmaceuticals Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Jounce Therapeutics Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Bispecific Antibody Product Profiles, Application and Specification
8.5.3 Jounce Therapeutics Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Eli Lilly Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Bispecific Antibody Product Profiles, Application and Specification
8.6.3 Eli Lilly Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 MacroGenics Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Bispecific Antibody Product Profiles, Application and Specification
8.7.3 MacroGenics Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Sanofi Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Bispecific Antibody Product Profiles, Application and Specification
8.8.3 Sanofi Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Genentech Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Bispecific Antibody Product Profiles, Application and Specification
8.9.3 Genentech Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Pieris Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Bispecific Antibody Product Profiles, Application and Specification
8.10.3 Pieris Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Neovii Biotech Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Bispecific Antibody Product Profiles, Application and Specification
8.11.3 Neovii Biotech Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Ablynx Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Bispecific Antibody Product Profiles, Application and Specification
8.12.3 Ablynx Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Emergent BioSolutions Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Bispecific Antibody Product Profiles, Application and Specification
8.13.3 Emergent BioSolutions Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Merus Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Bispecific Antibody Product Profiles, Application and Specification
8.14.3 Merus Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Genmab Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Bispecific Antibody Product Profiles, Application and Specification
8.15.3 Genmab Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 OncoMed Pharmaceuticals Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Bispecific Antibody Product Profiles, Application and Specification
8.16.3 OncoMed Pharmaceuticals Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Chugai Pharmaceutical Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Bispecific Antibody Product Profiles, Application and Specification
8.17.3 Chugai Pharmaceutical Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 EMD Serono Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Bispecific Antibody Product Profiles, Application and Specification
8.18.3 EMD Serono Sales, Revenue, Price, Gross Margin 2018-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Immunomedics Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Bispecific Antibody Product Profiles, Application and Specification
8.19.3 Immunomedics Sales, Revenue, Price, Gross Margin 2018-2021
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
8.20 Roche Market Performance Analysis
8.20.1 Company Profiles
8.20.2 Bispecific Antibody Product Profiles, Application and Specification
8.20.3 Roche Sales, Revenue, Price, Gross Margin 2018-2021
8.20.4 Company Recent Development
8.20.5 Strategies for Company to Deal with the Impact of COVID-19
8.21 Adimab Market Performance Analysis
8.21.1 Company Profiles
8.21.2 Bispecific Antibody Product Profiles, Application and Specification
8.21.3 Adimab Sales, Revenue, Price, Gross Margin 2018-2021
8.21.4 Company Recent Development
8.21.5 Strategies for Company to Deal with the Impact of COVID-19
8.22 Amgen Market Performance Analysis
8.22.1 Company Profiles
8.22.2 Bispecific Antibody Product Profiles, Application and Specification
8.22.3 Amgen Sales, Revenue, Price, Gross Margin 2018-2021
8.22.4 Company Recent Development
8.22.5 Strategies for Company to Deal with the Impact of COVID-19
8.23 NovImmune SA Market Performance Analysis
8.23.1 Company Profiles
8.23.2 Bispecific Antibody Product Profiles, Application and Specification
8.23.3 NovImmune SA Sales, Revenue, Price, Gross Margin 2018-2021
8.23.4 Company Recent Development
8.23.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Bispecific Antibody Market Analysis and Forecast by Type and Application
9.1 Global Bispecific Antibody Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Mab or Peptide Market Revenue and Volume Forecast (2021-2026)
9.1.2 BiTE Market Revenue and Volume Forecast (2021-2026)
9.1.3 Bispecific mAb Market Revenue and Volume Forecast (2021-2026)
9.1.4 CAR-T Market Revenue and Volume Forecast (2021-2026)
9.1.5 ADC Market Revenue and Volume Forecast (2021-2026)
9.1.6 Small Molecule Market Revenue and Volume Forecast (2021-2026)
9.2 Global Bispecific Antibody Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Primarily Oncology Market Revenue and Volume Forecast (2021-2026)
9.2.2 Solid Tumors Market Revenue and Volume Forecast (2021-2026)
9.2.3 Inflammation Market Revenue and Volume Forecast (2021-2026)
9.2.4 Cardiovascular Market Revenue and Volume Forecast (2021-2026)
9.2.5 General Medicine Market Revenue and Volume Forecast (2021-2026)

10 Bispecific Antibody Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Bispecific Antibody Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Healthcare IT Industry

Select License Type